Luke Pett is a Senior Executive in Business Development at Cancer Research Horizons, with previous experience in research and innovation at Cancer Research UK, as well as roles in formulation development and R&D at Merck and Reckitt Benckiser. Luke holds a PhD in Medical Sciences from UCL and a degree in Chemistry from The University of Sheffield.
October, 2021 - present